Skip to main content

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

Recruiting · Phase 2 · NCT06735248

Conditions: Multiple Sclerosis

At a glance

Research payments reported, 2025
$196,609
U.S. investigators named
11
Sites paid
23
Planned or actual enrollment
180

About the trial

Sponsor
ModernaTX, Inc.
Tested
mRNA-1195 (biological), Placebo (biological)
Dates
Started 2025-04-16; completion 2029-01-08
Results posted
Not yet

The primary objective of this trial is to evaluate the safety and reactogenicity of mRNA-1195 in participants with multiple sclerosis.

From ClinicalTrials.gov, last updated 2026-06-15. Full record, eligibility and contacts (opens in a new tab)

Industry funding

ModernaTX, Inc. reported $196,609 in research payments for this study in 2025 (81 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Anesc Research $40,629
  • Washington University $20,612
  • Quest Research Institute $18,659
  • Boston Clinical Trials LLC $18,485
  • Oklahoma Medical Research Foundation $15,750
  • North Texas Institute of Neurology & Headache (ntinh) - Plano $14,333
  • Sharlin Health & Neurology $14,217
  • Medstar Southern Maryland - Neurology $14,068
  • Boston Clinical Trials Inc $13,794
  • Medstar Research Institute $12,500
  • Saturn Research Solutions LLC $9,935
  • The University of Texas Southwestern Medical Center at Dallas $2,000
  • Advanced Neuroresearch Centers $378
  • The University of Texas Southw $320
  • Neurology Clinic, PC $265
  • Washington University School of Medicine Neurology Clinical Unit $239
  • Washu Medicine St Louis $184
  • Oklahoma Medical Research Foundation (omrf) Ms Center of Excellence $184
  • The Johns Hopkins Multiple Sclerosis (ms) Center - Neurology $55

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.